An Observational Research Study for Cancer Patients on Immune Checkpoint Inhibitors, DiRECT Study

Clinical trial NCT05364086 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05364086
Sponsor: University of Rochester NCORP Research Base
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Hematopoietic and Lymphoid Cell Neoplasm Malignant Solid Neoplasm

Start date: 2022-04-26
Primary completion: 2026-10-31
Enrollment: 2100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.